IBDEI2JG ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,40533,1,4,0)
;;=4^R63.3
;;^UTILITY(U,$J,358.3,40533,2)
;;=^5019541
;;^UTILITY(U,$J,358.3,40534,0)
;;=R63.4^^152^2012^33
;;^UTILITY(U,$J,358.3,40534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40534,1,3,0)
;;=3^Abnormal Weight Loss
;;^UTILITY(U,$J,358.3,40534,1,4,0)
;;=4^R63.4
;;^UTILITY(U,$J,358.3,40534,2)
;;=^5019542
;;^UTILITY(U,$J,358.3,40535,0)
;;=R63.5^^152^2012^32
;;^UTILITY(U,$J,358.3,40535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40535,1,3,0)
;;=3^Abnormal Weight Gain
;;^UTILITY(U,$J,358.3,40535,1,4,0)
;;=4^R63.5
;;^UTILITY(U,$J,358.3,40535,2)
;;=^5019543
;;^UTILITY(U,$J,358.3,40536,0)
;;=R64.^^152^2012^50
;;^UTILITY(U,$J,358.3,40536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40536,1,3,0)
;;=3^Cachexia
;;^UTILITY(U,$J,358.3,40536,1,4,0)
;;=4^R64.
;;^UTILITY(U,$J,358.3,40536,2)
;;=^17920
;;^UTILITY(U,$J,358.3,40537,0)
;;=R68.3^^152^2012^55
;;^UTILITY(U,$J,358.3,40537,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40537,1,3,0)
;;=3^Clubbing of Fingers
;;^UTILITY(U,$J,358.3,40537,1,4,0)
;;=4^R68.3
;;^UTILITY(U,$J,358.3,40537,2)
;;=^5019553
;;^UTILITY(U,$J,358.3,40538,0)
;;=R73.01^^152^2012^94
;;^UTILITY(U,$J,358.3,40538,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40538,1,3,0)
;;=3^Impaired Fasting Glucose
;;^UTILITY(U,$J,358.3,40538,1,4,0)
;;=4^R73.01
;;^UTILITY(U,$J,358.3,40538,2)
;;=^5019561
;;^UTILITY(U,$J,358.3,40539,0)
;;=R73.02^^152^2012^95
;;^UTILITY(U,$J,358.3,40539,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40539,1,3,0)
;;=3^Impaired Glucose Tolerance (oral)
;;^UTILITY(U,$J,358.3,40539,1,4,0)
;;=4^R73.02
;;^UTILITY(U,$J,358.3,40539,2)
;;=^5019562
;;^UTILITY(U,$J,358.3,40540,0)
;;=R73.09^^152^2012^18
;;^UTILITY(U,$J,358.3,40540,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40540,1,3,0)
;;=3^Abnormal Glucose NEC
;;^UTILITY(U,$J,358.3,40540,1,4,0)
;;=4^R73.09
;;^UTILITY(U,$J,358.3,40540,2)
;;=^5019563
;;^UTILITY(U,$J,358.3,40541,0)
;;=R73.9^^152^2012^89
;;^UTILITY(U,$J,358.3,40541,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40541,1,3,0)
;;=3^Hyperglycemia,Unspec
;;^UTILITY(U,$J,358.3,40541,1,4,0)
;;=4^R73.9
;;^UTILITY(U,$J,358.3,40541,2)
;;=^5019564
;;^UTILITY(U,$J,358.3,40542,0)
;;=R76.11^^152^2012^147
;;^UTILITY(U,$J,358.3,40542,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40542,1,3,0)
;;=3^Positive PPD
;;^UTILITY(U,$J,358.3,40542,1,4,0)
;;=4^R76.11
;;^UTILITY(U,$J,358.3,40542,2)
;;=^5019570
;;^UTILITY(U,$J,358.3,40543,0)
;;=R79.1^^152^2012^3
;;^UTILITY(U,$J,358.3,40543,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40543,1,3,0)
;;=3^Abnormal Coagulation Profile
;;^UTILITY(U,$J,358.3,40543,1,4,0)
;;=4^R79.1
;;^UTILITY(U,$J,358.3,40543,2)
;;=^5019591
;;^UTILITY(U,$J,358.3,40544,0)
;;=R82.5^^152^2012^74
;;^UTILITY(U,$J,358.3,40544,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40544,1,3,0)
;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
;;^UTILITY(U,$J,358.3,40544,1,4,0)
;;=4^R82.5
;;^UTILITY(U,$J,358.3,40544,2)
;;=^5019605
;;^UTILITY(U,$J,358.3,40545,0)
;;=R82.6^^152^2012^30
;;^UTILITY(U,$J,358.3,40545,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40545,1,3,0)
;;=3^Abnormal Urine Levels of Subst of Nonmed Source
;;^UTILITY(U,$J,358.3,40545,1,4,0)
;;=4^R82.6
;;^UTILITY(U,$J,358.3,40545,2)
;;=^5019606
;;^UTILITY(U,$J,358.3,40546,0)
;;=R82.90^^152^2012^29
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2JG 3747 printed Apr 09, 2024@22:00:34 Page 2
IBDEI2JG ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,40533,1,4,0)
+2 ;;=4^R63.3
+3 ;;^UTILITY(U,$J,358.3,40533,2)
+4 ;;=^5019541
+5 ;;^UTILITY(U,$J,358.3,40534,0)
+6 ;;=R63.4^^152^2012^33
+7 ;;^UTILITY(U,$J,358.3,40534,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,40534,1,3,0)
+10 ;;=3^Abnormal Weight Loss
+11 ;;^UTILITY(U,$J,358.3,40534,1,4,0)
+12 ;;=4^R63.4
+13 ;;^UTILITY(U,$J,358.3,40534,2)
+14 ;;=^5019542
+15 ;;^UTILITY(U,$J,358.3,40535,0)
+16 ;;=R63.5^^152^2012^32
+17 ;;^UTILITY(U,$J,358.3,40535,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,40535,1,3,0)
+20 ;;=3^Abnormal Weight Gain
+21 ;;^UTILITY(U,$J,358.3,40535,1,4,0)
+22 ;;=4^R63.5
+23 ;;^UTILITY(U,$J,358.3,40535,2)
+24 ;;=^5019543
+25 ;;^UTILITY(U,$J,358.3,40536,0)
+26 ;;=R64.^^152^2012^50
+27 ;;^UTILITY(U,$J,358.3,40536,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,40536,1,3,0)
+30 ;;=3^Cachexia
+31 ;;^UTILITY(U,$J,358.3,40536,1,4,0)
+32 ;;=4^R64.
+33 ;;^UTILITY(U,$J,358.3,40536,2)
+34 ;;=^17920
+35 ;;^UTILITY(U,$J,358.3,40537,0)
+36 ;;=R68.3^^152^2012^55
+37 ;;^UTILITY(U,$J,358.3,40537,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,40537,1,3,0)
+40 ;;=3^Clubbing of Fingers
+41 ;;^UTILITY(U,$J,358.3,40537,1,4,0)
+42 ;;=4^R68.3
+43 ;;^UTILITY(U,$J,358.3,40537,2)
+44 ;;=^5019553
+45 ;;^UTILITY(U,$J,358.3,40538,0)
+46 ;;=R73.01^^152^2012^94
+47 ;;^UTILITY(U,$J,358.3,40538,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,40538,1,3,0)
+50 ;;=3^Impaired Fasting Glucose
+51 ;;^UTILITY(U,$J,358.3,40538,1,4,0)
+52 ;;=4^R73.01
+53 ;;^UTILITY(U,$J,358.3,40538,2)
+54 ;;=^5019561
+55 ;;^UTILITY(U,$J,358.3,40539,0)
+56 ;;=R73.02^^152^2012^95
+57 ;;^UTILITY(U,$J,358.3,40539,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,40539,1,3,0)
+60 ;;=3^Impaired Glucose Tolerance (oral)
+61 ;;^UTILITY(U,$J,358.3,40539,1,4,0)
+62 ;;=4^R73.02
+63 ;;^UTILITY(U,$J,358.3,40539,2)
+64 ;;=^5019562
+65 ;;^UTILITY(U,$J,358.3,40540,0)
+66 ;;=R73.09^^152^2012^18
+67 ;;^UTILITY(U,$J,358.3,40540,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,40540,1,3,0)
+70 ;;=3^Abnormal Glucose NEC
+71 ;;^UTILITY(U,$J,358.3,40540,1,4,0)
+72 ;;=4^R73.09
+73 ;;^UTILITY(U,$J,358.3,40540,2)
+74 ;;=^5019563
+75 ;;^UTILITY(U,$J,358.3,40541,0)
+76 ;;=R73.9^^152^2012^89
+77 ;;^UTILITY(U,$J,358.3,40541,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,40541,1,3,0)
+80 ;;=3^Hyperglycemia,Unspec
+81 ;;^UTILITY(U,$J,358.3,40541,1,4,0)
+82 ;;=4^R73.9
+83 ;;^UTILITY(U,$J,358.3,40541,2)
+84 ;;=^5019564
+85 ;;^UTILITY(U,$J,358.3,40542,0)
+86 ;;=R76.11^^152^2012^147
+87 ;;^UTILITY(U,$J,358.3,40542,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,40542,1,3,0)
+90 ;;=3^Positive PPD
+91 ;;^UTILITY(U,$J,358.3,40542,1,4,0)
+92 ;;=4^R76.11
+93 ;;^UTILITY(U,$J,358.3,40542,2)
+94 ;;=^5019570
+95 ;;^UTILITY(U,$J,358.3,40543,0)
+96 ;;=R79.1^^152^2012^3
+97 ;;^UTILITY(U,$J,358.3,40543,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,40543,1,3,0)
+100 ;;=3^Abnormal Coagulation Profile
+101 ;;^UTILITY(U,$J,358.3,40543,1,4,0)
+102 ;;=4^R79.1
+103 ;;^UTILITY(U,$J,358.3,40543,2)
+104 ;;=^5019591
+105 ;;^UTILITY(U,$J,358.3,40544,0)
+106 ;;=R82.5^^152^2012^74
+107 ;;^UTILITY(U,$J,358.3,40544,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,40544,1,3,0)
+110 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
+111 ;;^UTILITY(U,$J,358.3,40544,1,4,0)
+112 ;;=4^R82.5
+113 ;;^UTILITY(U,$J,358.3,40544,2)
+114 ;;=^5019605
+115 ;;^UTILITY(U,$J,358.3,40545,0)
+116 ;;=R82.6^^152^2012^30
+117 ;;^UTILITY(U,$J,358.3,40545,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,40545,1,3,0)
+120 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
+121 ;;^UTILITY(U,$J,358.3,40545,1,4,0)
+122 ;;=4^R82.6
+123 ;;^UTILITY(U,$J,358.3,40545,2)
+124 ;;=^5019606
+125 ;;^UTILITY(U,$J,358.3,40546,0)
+126 ;;=R82.90^^152^2012^29
